Home › Funds › GREENWOOD CAPITAL ASSOCIATES LLC › REGN

GREENWOOD CAPITAL ASSOCIATES LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

GREENWOOD CAPITAL ASSOCIATES LLC reported holding 11,816 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$9.0M, representing 0.87% of its reported portfolio and ranking #28 among its reported holdings. GREENWOOD CAPITAL ASSOCIATES LLC has disclosed REGN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)11.82K sh
Reported value held$8.96M
Portfolio Weight0.87%
First reportedQ1 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How GREENWOOD CAPITAL ASSOCIATES LLC's REGN position evolved

GREENWOOD CAPITAL ASSOCIATES LLC first disclosed a stake in REGN in Q1 2025 at 8,442 shares (US$5.4M). The position peaked in Q3 2026 at 11,816 shares, worth US$9.0M. Across 7 filings, GREENWOOD CAPITAL ASSOCIATES LLC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 11,816 shares valued at US$9.0M — a reduction of -2,057 shares quarter over quarter.. Notable position changes include a 52% increase in Q2 2025 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 8.44K $5.35M New
Q2 2025 12.86K $6.75M Add
Q3 2025 12.59K $7.08M Reduce
Q4 2025 11.53K $8.90M Reduce
Q1 2026 11.26K $8.70M Reduce
Q2 2026 13.87K $8.65M Add
Q3 2026 11.82K $8.96M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has GREENWOOD CAPITAL ASSOCIATES LLC held REGN?

GREENWOOD CAPITAL ASSOCIATES LLC has disclosed REGN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is GREENWOOD CAPITAL ASSOCIATES LLC's current position in REGN?

As of Q3 2026, GREENWOOD CAPITAL ASSOCIATES LLC holds 11.82K shares of REGN (REGENERON PHARMACEUTICALS), valued at $8.96M, representing 0.87% of its reported portfolio and ranking #28.

Has GREENWOOD CAPITAL ASSOCIATES LLC been buying or selling REGN?

In the latest 13F filing (Q3 2026), GREENWOOD CAPITAL ASSOCIATES LLC reduced its position in REGN. The position peaked in Q3 2026 at 11.82K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.